Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimotuzumab and Chemoradiotherapy in Inoperable or Recurrent Gastric Cancer
NCT01180166Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- May 2010
- Primary completion
- Sep 2013
- Countries
- 1
01
Overview
A Phase 2 trial of nimotuzumab in gastric cancer (GC), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
nimotuzumab
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01180166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01180166.